Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE0005664809
Fri, 08.10.2021
Evotec SE
INCLUDES NEW CELL TYPES FOR STUDYING MOLECULAR DISEASE SIGNATURES FOR DISCOVERY OF DISEASE-MODIFYING THERAPIES FOR NEURODEGENERATIVE DISEASES
TRIGGERS US$ 9.0 M PAYMENT TO EVOTEC
Hamburg, Germany, 08 October 2021:
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) announced today that its collaboration with Bristol Myers Sq [ … ]
Thu, 02.09.2021
Evotec SE
BRISTOL MYERS SQUIBB EXERCISES ITS OPTION TO ENTER INTO A GLOBAL LICENSE AGREEMENT FOR THE FIRST PROGRAMME FROM THE COMPANIES' ALLIANCE IN NEURODEGENERATION
THE EVT8683 IND FILING HAS RECEIVED FDA CLEARANCE
THE PROGRAMME (EVT8683) ORIGINATES FROM A PHENOTYPIC SCREEN CONDUCTED BY EVOTEC USING ITS LEADING IPSC (INDUCED PLURIPOTENT STEM CELL) DRUG D [ … ]
Wed, 11.08.2021
Evotec SE
J.POD(R) 1 US PROVIDES UNIQUELY FLEXIBLE CGMP MANUFACTURING OF KILOGRAMS TO METRIC TONS OF BIOLOGICS THERAPEUTICS
J.POD(R) FACILITY EXPANDS JUST - EVOTEC BIOLOGICS' CAPABILITIES INTO COMMERCIAL BIOLOGICS MANUFACTURING AND ADDS LATE STAGE CLINICAL DEVELOPMENT AND COMMERCIAL SUPPLY FOR BOTH SMALL AND LARGE QUANTITIES OF DRUG SUBSTANCE
Hamburg, Germa [ … ]
Wed, 11.08.2021
Evotec SE
STRONG OVERALL PERFORMANCE IN THE FIRST HALF OF 2021 GAINING SPEED
RAPID CAPACITY BUILD-UP TO FOSTER UNDISRUPTED GROWTH AND FUTURE MARGIN EXPANSION
REGISTRATION STATEMENT FOR PROPOSED OFFERING OF AMERICAN DEPOSITARY SHARES SUBMITTED
GUIDANCE FOR FULL-YEAR 2021 CONFIRMED
WEBCAST AND CONFERENCE CALL TODAY AT 02.00 PM CEST
Hamburg, Germany, 11 [ … ]
Wed, 04.08.2021
Evotec SE
Hamburg, Germany, 04 August 2021:
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) will announce its financial results for the first half-year 2021 on Wednesday, 11 August 2021.
The Company is going to hold a conference call to discuss the results as well as to provide an update on its performance. The conference call [ … ]
Thu, 01.07.2021
Evotec SE
EVOTEC ACQUIRES THE VERONA SITE FROM GSK AND SECURES CAPACITY FOR LONG-TERM GROWTH
EMPLOYEES VOTE FOR SITE TO BE NAMED "CAMPUS LEVI-MONTALCINI" IN HONOUR OF ITALIAN NOBEL LAUREATE RITA LEVI-MONTALCINI
Hamburg, Germany, 01 July 2021:
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) today announced that Evotec has added sig [ … ]
Tue, 15.06.2021
Evotec SE
ALL AGENDA ITEMS ADOPTED WITH THE REQUIRED MAJORITY
DR CONSTANZE ULMER-EILFORT ELECTED AS NEW MEMBER OF THE SUPERVISORY BOARD
PROF. DR WOLFGANG PLISCHKE RESIGNS FROM HIS OFFICE AS CHAIRMAN OF THE SUPERVISORY BOARD
Hamburg, Germany, 15 June 2021:
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) today announced that its sh [ … ]
Tue, 15.06.2021
Evotec SE
INTEGRATED PLATFORM APPROACH TO RESPOND TO THE CHALLENGES OF PANDEMIC PREPAREDNESS, RAPID RESPONSE AND DELIVERABILITY
PRROTECT COMBINES FIRST-IN-CLASS PROGRAMMES ACROSS THERAPEUTIC MODALITIES, ACCELERATED R&D TIMELINES FOR HIGHLY EFFECTIVE NEUTRALISING ANTIBODIES WITH AI/ML PREDICTION TOOLS (J.HAL℠) AND MANUFACTURING PLATFORM (J.POD(R))
Hambur [ … ]
Tue, 11.05.2021
Evotec SE
SUCCESSFUL START TO 2021 WITH STRONG STRATEGIC POSITION AND LONG-TERM STRATEGY: ACTION PLAN 2025 "THE DATA-DRIVEN R&D AUTOBAHN TO CURES"
GOOD PROGRESS WITHIN PRODUCT DEVELOPMENT PARTNERSHIPS AND CO-OWNED PORTFOLIO
CONTINUED POSITIVE FINANCIAL PERFORMANCE; NO MATERIAL IMPACT THROUGH COVID-19 PANDEMIC
Hamburg, Germany, 11 May 2021:
Evotec SE [ … ]
Thu, 06.05.2021
Evotec SE
beLAB1407 TRANSLATES ACADEMIC INNOVATION FROM LEADING ACADEMIC INSTITUTIONS IN THE UK
THE COLLABORATION LEVERAGES EVOTEC'S UNIQUE MULTIMODALITY PLATFORM TO VALIDATE FIRST-IN-CLASS THERAPEUTIC CONCEPTS FROM THE UNIVERSITIES OF BIRMINGHAM, EDINBURGH, NOTTINGHAM, AND DUNDEE
BRISTOL MYERS SQUIBB JOINS beLAB1407 AS A BIOPHARMA COLLABORATOR
Hamburg, Ge [ … ]